The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 265 of the 267 references it cites were found in a registry or an index.
Abstract
Immune checkpoint inhibitors (ICI) have led to profound and durable tumor regression in some patients with metastatic cancer diseases. However, many patients still do not derive benefit from immunotherapy. Here, the accumulation of immunosuppressive cell populations within the tumor microenvironment (TME), such as myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAM), and regulatory T cells (Treg), contributes to the development of immune resistance. MDSC and Treg expand systematically in tumor patients and inhibit T cell activation and T effector cell function. Numerous studies have shown that the immunosuppressive mechanisms exerted by those inhibitory cell populations comprise soluble immunomodulatory mediators and receptor interactions. The latter are also required for the crosstalk of MDSC and Treg, raising questions about the relevance of cell–cell contacts for the establishment of their inhibitory properties. This review aims to outline the current knowledge on the crosstalk between these two cell populations, issuing particularly the potential role of cell adhesion molecules. In this regard, we further discuss the relevance of β2 integrins, which are essential for the differentiation and function of leukocytes as well as for MDSC–Treg interaction. Lastly, we aim to describe the impact of such bidirectional crosstalk for basic and applied cancer research and discuss how the targeting of these pathways might pave the way for future approaches in immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Myeloid cell plasticity in cancer. Myeloid cell types originate from hematopoietic stem cells and multipotent immature myeloid progenitor cells in the bone marrow (BM). The differentiation toward the matured cell line (i.e., polymorphonuclear neutrophils (PMN)) is promoted by soluble mediators and chemokines. In cancer patients, the differentiation pathways are strongly affected by factors produced in the tumor microenvironment (TME) by stromal cells, immune cells, and tumor cells (e.g., granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-1β, IL-6, IL-10, IL-23, interferon-gamma (IFN-γ)). In particular, the TME promotes the polarization of macrophages toward immunosuppressive tumor-associated macrophages (TAM), which confer the inhibition of effector T cells (Teff) within the TME via various mechanisms [72]. PMN within the TME frequently show a polarization toward immunosuppressive TAN, which is driven by soluble factors such as transforming growth factor-β (TGF-β). Tumor-associated neutrophils (TAN) confer immunosuppression via multiple mechanisms. The most prominent effect of the aberrant differentiation includes the accumulation of granulocytic (G-MDSC) and monocytic (M-MDSC) myeloid-derived suppressor cells. Myeloid cells may act as an integrated system in the context of tumor immunity [49]. Depending on the structural composition of the TME, myeloid cells polarize from MDSC toward TAM or TAN or promote the tolerization of DC in the context of a nutrient-depleted, hypoxic, inflamed TME. Under normoxic conditions, IFN-γ and TNF-α have been found to reverse this polarization and promote MDSC differentiation toward immunogenic DC and inflammatory M1 macrophages. It remains questioned if MDSC and TAN undergo an irreversible polarization or can polarize to anti-tumor PMN [24].](https://figures.cochat.ai/paper-figures/b2217f656d3048098235e4ff91d84e33/the-functional-crosstalk-between-myeloid-derived-suppressor-cells-and-regulatory-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HIF activation within solid tumors leads to the release of chemokines that promote the recruitment of immunosuppressive cell types such as tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and regulatory T cell (Treg) cells, which can limit the anti-tumor activity of Natural Killer and CD8 + T cells (Figure 1) [67].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MDSCs attenuate anti-tumor immunity particularly the activity of T cells, by secreting factors such as arginase-1 (Arg-1), inducible nitric oxide synthase (iNOS), and reactive oxygen species (ROS), thereby facilitating tumor cells to evade immune surveillance [27].”
From Advances on immunotherapy for osteosarcoma (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 6×
“These factors prevent APC maturation, impair Teff functions, and thus counteract the tumoricidal functions of activated immune effector cells [14,24,46,53].”
BackgroundInfluentialSafety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 19×
“Likewise, M-MDSC, despite their similarity in morphology and phenotype with other monocytic cell populations, are a functionally distinct population.”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“Particularly, they showed a strong expression of inducible NO-synthase (iNOS) and Arg-1, which explains their highly immunosuppressive character [49,74].”
BackgroundCancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393 · cited 2×
“Further contributing to the high plasticity of MDSC phenotypes are the temporal variations in the context of tumor-immune editing, as the TME is subject to permanent modulations in the course of the malignant transformation [39,55].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286 · cited 1×
“, a high mutational load of the tumor cells [3,4], the presence of neoantigens [5,6], microsatellite instability [7,8], and host factors, i.”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · cited 1×
“However, in the course of tumor development, a chronic inflammatory state is frequently being induced, which includes the elevation of proinflammatory mediators, the infiltration of regulatory immune cells, and the recruitment of endothelial cells and fibroblasts [30,33].”
BackgroundMacrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840 · cited 1×
“Further contributing to the high plasticity of MDSC phenotypes are the temporal variations in the context of tumor-immune editing, as the TME is subject to permanent modulations in the course of the malignant transformation [39,55].”
BackgroundMicroenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 9×
“For example, the culture of tumor-derived MDSC in the absence of tumor-derived factors was repetitively shown to result in the generation of mature macrophages, PMN, and DC [50,69–71], whereas the presence of tumor-derived factors or the adoptive transfer of MDSC into tumor-bearing hosts promoted their differentiation…”
BackgroundInfluentialRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751 · cited 1×
“There are currently two main subsets of MDSC to be distinguished: granulocytic (G)-MDSC and monocytic (M)-MDSC [56].”
BackgroundNoman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166 · cited 1×
“HIF-1α also enhanced the expression of PD-L1, thereby promoting the suppressive capacities of MDSC and their interaction with Treg [168].”
BackgroundMichalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091 · cited 1×
“In contrast to Th cells and CTL, which rely largely on glycolysis, glucose transporter (GLUT)-1 expression, and on mammalian target of rapamycin (mTOR) signaling, to sustain their metabolic activity, Treg express low levels of GLUT-1, are negatively regulated by mTOR, and depend largely on oxidative phosphorylation an…”
BackgroundThe Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008 · cited 1×
“It has been demonstrated that the release of pro-inflammatory cytokines within the TME promotes the immunosuppressive potential of regulatory myeloid cells, such as tumor-associated neutrophils (TAN) [35–37], TAM [27,33,38–40], MDSC [28,41,42] and regulatory dendritic cells (DC) [43–45].”
BackgroundMyeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736 · cited 1×
“Thus, inflammation is considered a key driver of MDSC and macrophage crosstalk within the TME [128].”
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645 · cited 18×
“Likewise, M-MDSC, despite their similarity in morphology and phenotype with other monocytic cell populations, are a functionally distinct population.”
BackgroundResultInfluentialThe role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · cited 1×
“These cytokines generated by TAM and tumor cells promote an aberrant activation of myelopoiesis, resulting in a defective differentiation of myeloid progenitor cells toward MDSC, which exert a strong pro-tumor activity [46,47].”
BackgroundPredictive biomarkers for checkpoint inhibitor-based immunotherapy
Gibney, G. T., Weiner, L. M., & Atkins, M. B. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30406-5 · Cited by 1,635
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586 · cited 2×
“Both the depletion of L-tryptophan and the accumulation of kynurenines suppressed T cell activation and induced Treg in vitro [93,172].”
BackgroundHuang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435 · cited 3×
“In concert with the aforementioned molecules, the production of soluble mediators (IL-10 and TGF-β) may provide signals for the induction of Treg [151].”
BackgroundResultRole of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325 · cited 1×
“As LAG-3 is essential for maximal Treg suppressive function, including the secretion of the immunosuppressive cytokines IL-10 and TGF-ß [181], the induction of Treg [182], and their differentiation toward a regulatory phenotype [183], it is conceivable that LAG-3/MHCII interaction between Treg and MDSC could mutually…”
BackgroundNeutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285 · cited 1×
“In particular, the TME promotes the polarization of macrophages toward immunosuppressive tumor-associated macrophages (TAM), which confer the inhibition of effector T cells (Teff) within the TME via various mechanisms [72].”
BackgroundThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284 · cited 1×
“In contrast to Th cells and CTL, which rely largely on glycolysis, glucose transporter (GLUT)-1 expression, and on mammalian target of rapamycin (mTOR) signaling, to sustain their metabolic activity, Treg express low levels of GLUT-1, are negatively regulated by mTOR, and depend largely on oxidative phosphorylation an…”
BackgroundMovahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234 · cited 2×
“In parallel, it has been reported that hypoxia and hypoxia inducible factor 1α (HIF-1α) within the TME might be key drivers for the upregulation of immunosuppressive Arg-1 and iNOS in M-MDSC and may promote the differentiation of CD11b+ Ly6C+ M-MDSC into immunosuppressive TAM [53,75].”
BackgroundDiaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., & Montero, A. J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0523-4 · Cited by 1,215 · cited 1×
“Despite conflicting reports about MDSC surface marker expression, the clinical value of MDSC has readily been demonstrated: Recent reports highlighted that the frequency of MDSC per se may reflect the tumor burden of cancer patients, thus showing a strong correlation between a high MDSC frequency and a poor prognosis…”
BackgroundTakada, Y., Ye, X., & Simon, S. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-215 · Cited by 1,205
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174 · cited 3×
“Moreover, nitration mediates several molecular blocks in T cells, including conformational changes in the TCR–CD8 complex, which renders CTL unresponsive to antigenspecific stimulation [87].”
BackgroundCorzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
History of myeloid-derived suppressor cells
Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148 · cited 2×
“The trafficking of MDSC and Treg to the tumor site is mediated via VLA-4 and β2 integrins [217,238].”
BackgroundMacintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.05.004 · Cited by 1,127 · cited 1×
“Whereas the depletion of nutrients and oxygen within the TME comprises T cell function [97,98], tumor hypoxia and lactate accumulation drive HIF-1α stabilization in MDSC, thus upregulating PD-L1 expression and promoting a metabolic switch to fatty acid oxidation (FAO).”
BackgroundSchmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 1,010
Chambers, C. A., Kuhns, M. S., Egen, J. G., & Allison, J. P. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.565 · Cited by 998 · cited 1×
“This interaction causes an impairment of APC-dependent T cell activation [108], enhances the immunosuppressive properties of Treg, and augments peripheral tolerance [109].”
BackgroundShang, B., Liu, Y., Jiang, S.-J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep15179 · Cited by 985 · cited 1×
“Next to the immunosuppressive effects conferred by soluble mediators and leukocyte receptor interactions, the extensive infiltration of the tumor by immunosuppressive cell populations, such as tumor-associated macrophages (TAM) [16,17], myeloid-derived suppressor cells (MDSC) [18], and regulatory T cells (Treg) [19,20…”
BackgroundLAG 3 (CD 223) as a cancer immunotherapy target
Andrews, L. P., Marciscano, A. E., Drake, C. G., & Vignali, D. A. A. (2017) · Immunological Reviews · doi:10.1111/imr.12519 · Cited by 956
Joller, N., Lozano, E., Burkett, P. R., Patel, B., Xiao, S., Zhu, C., Xia, J., Tan, T. G., Sefik, E., Yajnik, V., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.012 · Cited by 955 · cited 1×
“More recently, Wu and coworkers reported that the interaction of TIGIT and CD155 on MDSC might equally be involved in Treg–MDSC crosstalk [121,189], as it added up to the immunoregulatory functions of Treg [190] and MDSC [122].”
BackgroundMyeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2587 · Cited by 949 · cited 1×
“This involves the Arg-1-dependent consumption of L-arginine and deprivation of L-cysteine via its consumption and sequestration in MDSC [91], which causes the proliferative arrest of antigen-activated T cells due to the downregulation of the TCR (T cell receptor) complex and a cell cycle arrest in the G0-G1 phase [49,…”
BackgroundL-arginine availability regulates T-lymphocyte cell-cycle progression.
Rodriguez, P. C., Quiceno, D. G., & Ochoa, A. C. (2007) · Blood · doi:10.1182/blood-2006-06-031856 · Cited by 926 · cited 1×
“Similar to TAM and MDSC, Treg contribute to Arg-1 mediated arginine depletion within the TME [142].”
BackgroundLi, C., Jiang, P., Wei, S., Xu, X., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01234-1 · Cited by 921 · cited 22×
“Furthermore, Treg hamper anti-tumor immunity via the interaction of CTLA-4 with the co-stimulatory receptors CD80 and CD86, which are expressed by APC-like DC, resulting in the inhibition Cancers 2021, 13, 210 12 of 34 of their T cell stimulatory capacity [130,147].”
BackgroundInfluentialCheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902 · cited 1×
“Further, STAT-3 has been identified as a crucial regulator of MDSC expansion that conveys the recruitment of MDSC to the tumor site by upregulating the pro-inflammatory S100A8 and S100A9 proteins [85].”
BackgroundNakaya, M., Xiao, Y., Zhou, X., Chang, J.-H., Chang, M., Cheng, X., Blonska, M., Lin, X., & Sun, S.-C. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.007 · Cited by 866 · cited 1×
“In contrast to Teff, Treg are largely unaffected by limitations of either glutamine or leucine within the TME [143].”
BackgroundZea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851 · cited 1×
“This phenomenon could be reversed by the replenishment of L-arginine in vitro, but more importantly, in vivo studies reported that the depletion of G-MDSC re-established T cell growth, emphasizing their role in cancer immunosuppression [92].”
ResultJuneja, V. R., McGuire, K. A., Manguso, R. T., LaFleur, M. W., Collins, N., Haining, W. N., Freeman, G. J., & Sharpe, A. H. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160801 · Cited by 851 · cited 1×
“Furthermore, several checkpoint molecules were shown to be critically involved in MDSCmediated immunosuppression: Among these, PD-L1 and CTLA-4 are prominent negative regulators of T cell functions [106].”
BackgroundKusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850 · cited 2×
“Peroxynitrite is produced by the cooperative activities of Nox-2, Arg-1, and iNOS [24,101].”
BackgroundSinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847
Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.014 · Cited by 845 · cited 1×
“targeting CXCR2 in combination with anti-PD1 treatment revealed that the inhibition of MDSC trafficking into the tumor could equally restore intra-tumoral T cell infiltration and improve ICI efficacy in terms of overall survival [260].”
BackgroundImmunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
Groth, C., Hu, X., Weber, R., Fleming, V., Altevogt, P., Utikal, J., & Umansky, V. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0333-1 · Cited by 839 · cited 4×
“PD-L1 exerts its effects via ligation of PD-1 on T cells, resulting in T cell anergy and apoptosis [104], promoting the induction and function of Treg [107] and thus contributing to tumor immune evasion.”
BackgroundInfluentialA subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.-W., Ulfman, L. H., Leenen, L. P., Pickkers, P., & Koenderman, L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57990 · Cited by 828 · cited 2×
“Mac-1 MDSC and T cells human Acute systemic inflammation Mac-1 and ROS production were required for the inhibition of T cell function by a suppressive subset of human PMN [157]”
BackgroundLindau, D., Gielen, P., Kroesen, M., Wesseling, P., & Adema, G. J. (2013) · Immunology · doi:10.1111/imm.12036 · Cited by 815 · cited 10×
“These factors prevent APC maturation, impair Teff functions, and thus counteract the tumoricidal functions of activated immune effector cells [14,24,46,53].”
BackgroundInfluentialHoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793 · cited 1×
“Subsequent reports further revealed that IFN-γ and IL-10 are required for the production of both TGF-β and IL10 by MDSC in tumor-bearing mice [125,151,159].”
ResultTumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 792 · cited 2×
“Other suppressive properties of MDSC are controlled by signal transducer and activator of transcription (STAT)-1 and STAT-6, which regulate myeloid cells by inducing iNOS and Arg-1 expression [69,83].”
BackgroundKohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776 · cited 1×
“It has been shown as early as 2005 that MDSC promote Treg proliferation in vivo in a TGF-β-dependent manner [158].”
BackgroundAn immune-active tumor microenvironment favors clinical response to ipilimumab
Ji, R.-R., Chasalow, S. D., Wang, L., Hamid, O., Schmidt, H., Cogswell, J., Alaparthy, S., Berman, D., Jure-Kunkel, M., Siemers, N. O., et al. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1172-6 · Cited by 775 · cited 1×
“So far, the various immunosuppressive mechanisms, being present both locally within the tumor microenvironment (TME) and in lymphoid organs, have been identified as major factors mediating immune resistance [15].”
BackgroundRodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773 · cited 2×
“In general, G-MDSC have been found to be the main MDSC subset in patients with renal cell carcinoma [68], whereas M-MDSC constitute the dominant immunosuppressive MDSC”
BackgroundCell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Harjunpää, H., Llort Asens, M., Guenther, C., & Fagerholm, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01078 · Cited by 764 · cited 2×
“Given the essential role of β2 integrins in conferring the suppression of effector cell functions in these pathophysiological models, it is plausible that integrins might also contribute to the inhibition of anti-tumor immune responses [220].”
BackgroundMechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., & Gabrilovich, D. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900092 · Cited by 763 · cited 3×
“found an upregulation of ROS in G-MDSC isolated from seven different murine tumor models and in tumor-derived G-MDSC obtained from patients with head neck cancer [86].”
BackgroundInfluentialProstaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 755 · cited 1×
“Tumor-derived TGF-β has also been found to regulate MDSC accumulation and the polarization of other myeloid cell populations, such as tumor-infiltrating PMN toward an immunosuppressive phenotype [80].”
BackgroundHuman FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Wing, J. B., Tanaka, A., & Sakaguchi, S. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.020 · Cited by 726 · cited 5×
“CD4+CD25hi Forkhead-Box-Protein P3 (FoxP3)+ Treg cells are frequently found in the course of tumor progression and counteract APC activity, T cell activation, and anti-tumor functions of effector T cells (Teff) [24,52].”
BackgroundInfluentialProinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4666 · Cited by 725 · cited 5×
“Further, STAT-3 has been identified as a crucial regulator of MDSC expansion that conveys the recruitment of MDSC to the tumor site by upregulating the pro-inflammatory S100A8 and S100A9 proteins [85].”
BackgroundInfluentialMyeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690 · cited 2×
“with IL-2 receptor signaling [102] and leads to the nitration of CCL-2 chemokines.”
BackgroundKim, K., Skora, A. D., Li, Z., Liu, Q., Tam, A. J., Blosser, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410626111 · Cited by 676
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652 · cited 1×
“Otherwise, at the tumor site [53,89] and in the periphery [90], MDSC can suppress nearby T cells in an antigen-independent manner.”
BackgroundChemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101956 · Cited by 650 · cited 1×
“Consequently, antigen-specific CTLs do not infiltrate into the tumor but instead remain in the tumor-surrounding stroma [79].”
BackgroundFilipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647 · cited 2×
“subpopulation in melanomas or head–neck cancer [60,65].”
BackgroundBv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643 · cited 3×
“, the interaction of membrane-bound TGF-β with the NK cell receptor NKp30 [49,125,126].”
BackgroundResultAnderson, D. C., Schmalsteig, F. C., Finegold, M. J., Hughes, B. J., Rothlein, R., Miller, L. J., Kohl, S., Tosi, M. F., Jacobs, R. L., Waldrop, T. C., et al. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/152.4.668 · Cited by 634 · cited 1×
“The inability of the immune system of LAD1 patients to control infectious diseases mainly results from the functional defects of PMN, monocytes, and macrophages, which constitute the first line of cellular innate immunity [223].”
BackgroundMyeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630 · cited 2×
“In parallel, it has been reported that hypoxia and hypoxia inducible factor 1α (HIF-1α) within the TME might be key drivers for the upregulation of immunosuppressive Arg-1 and iNOS in M-MDSC and may promote the differentiation of CD11b+ Ly6C+ M-MDSC into immunosuppressive TAM [53,75].”
BackgroundCoxon, A., Rieu, P., Barkalow, F. J., Askari, S., Sharpe, A. H., von Andrian, U. H., Arnaout, M. A., & Mayadas, T. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80278-2 · Cited by 627 · cited 1×
“Notably, both LFA-1 and Mac-1 have been implicated in Treg [207] and MDSC induction [246] and survival.”
BackgroundSchrock, A. B., Ouyang, C., Sandhu, J., Sokol, E., Jin, D., Ross, J. S., Miller, V. A., Lim, D., Amanam, I., Chao, J., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz134 · Cited by 617 · cited 1×
“, a high mutational load of the tumor cells [3,4], the presence of neoantigens [5,6], microsatellite instability [7,8], and host factors, i.”
BackgroundDougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588 · cited 1×
“FAO further induces Arg-1 expression, NO, and peroxynitrite generation, resulting in Teff impairment [99].”
BackgroundNgiow, S. F., von Scheidt, B., Akiba, H., Yagita, H., Teng, M. W. L., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0096 · Cited by 574 · cited 9×
“Checkpoint molecules contribute t the crosstalk b tween MDSC nd Treg via PD-L1/PD-1, CD80/CTLA-4, MHC-II/LAG-3 V domain-containi g immu oglobulin sup ess r of T-c ll activation (VISTA)-Ligand/VISTA, Gal-9/TIM-3 (not shown), or CD155/TIGIT (not shown) interaction, promoting the suppressive activities of MDSC and Treg.”
BackgroundInfluentialProstaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
Baratelli, F., Lin, Y., Zhu, L., Yang, S.-C., Heuzé-Vourc’h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., & Dubinett, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1483 · Cited by 573 · cited 1×
“On the other hand, PGE2 is known to enhance FoxP3 expression in Treg and thus promotes their inhibitory activity [170].”
BackgroundDolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939903 · Cited by 569 · cited 2×
“Moreover, it has been proposed that the relative amounts of G-CSF and M-CSF present within the bone marrow may account for the different shares of the aforementioned MDSC subsets [59].”
BackgroundTIGIT as an emerging immune checkpoint
Harjunpää, H., & Guillerey, C. (2020) · Clinical and Experimental Immunology · doi:10.1111/cei.13407 · Cited by 552 · cited 2×
“More recently, Wu and coworkers reported that the interaction of TIGIT and CD155 on MDSC might equally be involved in Treg–MDSC crosstalk [121,189], as it added up to the immunoregulatory functions of Treg [190] and MDSC [122].”
BackgroundTumor-associated macrophages: Functional diversity, clinical significance, and open questions
Biswas, S. K., Allavena, P., & Mantovani, A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0367-7 · Cited by 551
Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
Sawant, D. V., Yano, H., Chikina, M., Zhang, Q., Liao, M., Liu, C., Callahan, D. J., Sun, Z., Sun, T., Tabib, T., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0346-9 · Cited by 543
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.284 · Cited by 539 · cited 5×
“Further, STAT-3 has been identified as a crucial regulator of MDSC expansion that conveys the recruitment of MDSC to the tumor site by upregulating the pro-inflammatory S100A8 and S100A9 proteins [85].”
BackgroundInfluentialMyeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Weber, R., Fleming, V., Hu, X., Nagibin, V., Groth, C., Altevogt, P., Utikal, J., & Umansky, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01310 · Cited by 538 · cited 4×
“It has been reported in various preclinical tumor models that the targeting of MDSC potentiated the effect of ICI and led to a significantly increased survival [249,250].”
BackgroundMethodInfluentialTumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
Daud, A. I., Loo, K., Pauli, M. L., Sanchez-Rodriguez, R., Sandoval, P. M., Taravati, K., Tsai, K., Nosrati, A., Nardo, L., Alvarado, M. D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87324 · Cited by 525 · cited 2×
“, the frequency, composition, and activation status [9,10] of tumor-infiltrating lymphocytes (TIL), are predictive for the responsiveness toward ICI treatment.”
BackgroundYoun, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510 · cited 4×
“However, as compared to PMN, G-MDSC show a diminished phagocytic activity, produce higher levels of ROS, and suppress T cell activation upon activation (Table 1) [61].”
BackgroundInfluentialOstrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509 · cited 2×
“Most notably, recent reports suggest that MDSC-mediated immunosuppression substantially contributes to tumor immune evasion [28,251].”
BackgroundT cell receptor signalling in the control of regulatory T cell differentiation and function
Li, M. O., & Rudensky, A. Y. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.26 · Cited by 493 · cited 1×
“Treg are defined as a T helper cell subpopulation characterized by the co-expression of CD4, CD25, and in large parts of FoxP3, which inhibit the activation and differentiation of CD4+ and CD8+ T cells, subsequently impairing reactivity against autologous and tumor-expressed antigens [130,133,134].”
BackgroundVISTA Regulates the Development of Protective Antitumor Immunity
Le Mercier, I., Chen, W., Lines, J. L., Day, M., Li, J., Sergent, P., Noelle, R. J., & Wang, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1506 · Cited by 486 · cited 2×
“More interestingly, the antibody-mediated blockade of VISTA impaired the induction and suppressive function of Treg and reduced the overall number of MDSC [116,175].”
BackgroundMyeloid-Derived Suppressor Cells
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.04.002 · Cited by 482 · cited 3×
“This heterogeneity is in part due to the unique inflammatory milieu present within different tumor entities [41].”
BackgroundTumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Holmgaard, R. B., Zamarin, D., Li, Y., Gasmi, B., Munn, D. H., Allison, J. P., Merghoub, T., & Wolchok, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.077 · Cited by 482 · cited 3×
“Hence, IDO-induced Treg may play an important role in the recruitment and activation of MDSC [173].”
BackgroundInfluentialPan, P.-Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M., & Chen, S.-H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1882 · Cited by 467 · cited 6×
“CD40/CD40L MDSC and Treg mouse B16-OVA Melanoma CD40-deficient MDSC failed to induce Treg (after adoptive transfer) anti-CD40 antibody treatment promoted the differentiation of MDSC toward DC and macrophages [155]”
BackgroundResultInfluentialMyeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
Law, A. M. K., Valdes-Mora, F., & Gallego-Ortega, D. (2020) · Cells · doi:10.3390/cells9030561 · Cited by 455 · cited 5×
“Despite the lack of specific markers that reflect either the phenotype or the functional polarization of MDSC, the application of new multi-omics techniques might prospectively contribute to a more profound understanding of MDSC heterogeneity, their role in tumor progression, and enable the application of selective MD…”
BackgroundMethodInfluentialSTAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Kusmartsev, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4880 · Cited by 445 · cited 2×
“Other suppressive properties of MDSC are controlled by signal transducer and activator of transcription (STAT)-1 and STAT-6, which regulate myeloid cells by inducing iNOS and Arg-1 expression [69,83].”
BackgroundSchlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., & Cerwenka, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201018 · Cited by 438 · cited 1×
“further found that CCL-5-secretion by M-MDSC resulted in a direct CCR5-dependent recruitment of Treg, indicating that chemokines also add up to MDSC– Treg interaction in the TME [163].”
BackgroundMyeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., & Ostrand-Rosenberg, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804253 · Cited by 427 · cited 1×
“sion on CD4+ and CD8+ T cells, thereby limiting the recirculation into lymph nodes [105].”
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Colombo, M. P., & Piconese, S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2250 · Cited by 407 · cited 2×
“In accordance, the number of Treg circulating in the blood of cancer patients and the infiltration of Treg into the tumor have been documented to be closely related to the progression and prognosis of multiple cancer entities [20].”
BackgroundOhta, A., Kini, R., Ohta, A., Subramanian, M., Madasu, M., & Sitkovsky, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00190 · Cited by 398
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
Enk, A. H., Jonuleit, H., Saloga, J., & Knop, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3 · Cited by 386
The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
Long, L., Zhang, X., Chen, F., Pan, Q., Phiphatwatchara, P., Zeng, Y., & Chen, H. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.180 · Cited by 386
Poschke, I., Mougiakakos, D., Hansson, J., Masucci, G. V., & Kiessling, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3767 · Cited by 382 · cited 2×
“Hence, S100A9 protein has been proposed as a potential marker characterizing human CD14+ HLA-DR− M-MDSC.”
BackgroundImmune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
Liu, J., Yuan, Y., Chen, W., Putra, J., Suriawinata, A. A., Schenk, A. D., Miller, H. E., Guleria, I., Barth, R. J., Huang, Y. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420370112 · Cited by 374 · cited 1×
“More interestingly, the antibody-mediated blockade of VISTA impaired the induction and suppressive function of Treg and reduced the overall number of MDSC [116,175].”
BackgroundOrillion, A., Hashimoto, A., Damayanti, N., Shen, L., Adelaiye-Ogala, R., Arisa, S., Chintala, S., Ordentlich, P., Kao, C., Elzey, B., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0741 · Cited by 373
Mechanisms regulating T-cell infiltration and activity in solid tumors
Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369
Raychaudhuri, B., Rayman, P., Ireland, J., Ko, J., Rini, B., Borden, E. C., Garcia, J., Vogelbaum, M. A., & Finke, J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor042 · Cited by 359 · cited 1×
“Despite conflicting reports about MDSC surface marker expression, the clinical value of MDSC has readily been demonstrated: Recent reports highlighted that the frequency of MDSC per se may reflect the tumor burden of cancer patients, thus showing a strong correlation between a high MDSC frequency and a poor prognosis…”
BackgroundTeixidó, J., Hemler, M. E., Greenberger, J. S., & Anklesaria, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115870 · Cited by 359 · cited 10×
“In order to exert immunosuppressive functions, Treg express high levels of ICAM-1, P-Selectin, and the integrin a4b1 (very late antigen-4; VLA-4) allowing the quick migration to the site of inflammation [217].”
BackgroundInfluentialImmunosuppression associated with chronic inflammation in the tumor microenvironment
Wang, D., & DuBois, R. N. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv123 · Cited by 355 · cited 2×
“In concert with these soluble mediators, cell–cell-based interactions such as the programmed death protein (PD)1/PD-ligand (L)-1 axis contribute to the intense crosstalk between the immunosuppressive cell populations, subsequently enhancing the tumor-supporting capacity of the TME, which tips the scale toward immunosu…”
BackgroundCCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Huang, B., Lei, Z., Zhao, J., Gong, W., Liu, J., Chen, Z., Liu, Y., Li, D., Yuan, Y., Zhang, G.-M., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.012 · Cited by 349
Ahn, G.-O., Tseng, D., Liao, C.-H., Dorie, M. J., Czechowicz, A., & Brown, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911378107 · Cited by 347 · cited 1×
“Other observations revealed that a systemic application of CD11b blocking antibodies after radiation increased anti-tumor immune responses, which has been explained by a reduced myeloid cell migration to the tumor site and an attenuated support of tumor neovascularization [230].”
BackgroundMeyer, C., Sevko, A., Ramacher, M., Bazhin, A. V., Falk, C. S., Osen, W., Borrello, I., Kato, M., Schadendorf, D., Baniyash, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108121108 · Cited by 346 · cited 1×
“Hence, the proliferation, activation, and retention of highly immunosuppressive MDSC are not only induced by the chronic inflammatory state within the TME, but it further enhances these conditions, thus creating a positive feedback loop [34,51].”
BackgroundCD80 in Immune Suppression by Mouse Ovarian Carcinoma–Associated Gr-1+CD11b+ Myeloid Cells
Yang, R., Cai, Z., Zhang, Y., Yutzy, W. H., Roby, K. F., & Roden, R. B. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3755 · Cited by 343 · cited 4×
“Vice versa, it has been observed that MDSC enhanced the immunosuppressive properties of Treg in a mouse ovarian cancer model through the interaction of CTLA-4 with CD80 on MDSC [156].”
BackgroundInfluentialSolito, S., Falisi, E., Diaz-Montero, C. M., Doni, A., Pinton, L., Rosato, A., Francescato, S., Basso, G., Zanovello, P., Onicescu, G., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325753 · Cited by 337 · cited 3×
“Despite conflicting reports about MDSC surface marker expression, the clinical value of MDSC has readily been demonstrated: Recent reports highlighted that the frequency of MDSC per se may reflect the tumor burden of cancer patients, thus showing a strong correlation between a high MDSC frequency and a poor prognosis…”
BackgroundInfectious tolerance via the consumption of essential amino acids and mTOR signaling
Cobbold, S. P., Adams, E., Farquhar, C. A., Nolan, K. F., Howie, D., Lui, K. O., Fairchild, P. J., Mellor, A. L., Ron, D., & Waldmann, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903919106 · Cited by 336 · cited 1×
“In the course of this interaction, it has been found that Treg might enhance immunosuppression via the upregulation of IDO and Arg-1 on APC, which impaired the induction of Teff and in turn also inhibited mTOR signaling in Treg [148,149].”
BackgroundTargeting the indoleamine 2,3-dioxygenase pathway in cancer
Moon, Y. W., Hajjar, J., Hwu, P., & Naing, A. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0094-9 · Cited by 336 · cited 1×
“IDO is known to catabolize the rate-limiting step of the kynurenine pathway, which resulted in lower tryptophan levels and the accumulation of kynurenines within the TME [171].”
BackgroundDe Cicco, P., Ercolano, G., & Ianaro, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01680 · Cited by 332 · cited 1×
“Most notably, recent reports suggest that MDSC-mediated immunosuppression substantially contributes to tumor immune evasion [28,251].”
BackgroundImmunometabolism of regulatory T cells
Newton, R., Priyadharshini, B., & Turka, L. A. (2016) · Nature Immunology · doi:10.1038/ni.3466 · Cited by 329 · cited 1×
“In the course of this interaction, it has been found that Treg might enhance immunosuppression via the upregulation of IDO and Arg-1 on APC, which impaired the induction of Teff and in turn also inhibited mTOR signaling in Treg [148,149].”
BackgroundProgrammed Death Ligand 2 in Cancer-Induced Immune Suppression
Rozali, E. N., Hato, S. V., Robinson, B. W., Lake, R. A., & Lesterhuis, W. J. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/656340 · Cited by 328 · cited 1×
“Youn and coworkers additionally suggested that PD-L2 might add up to MDSCinduced T cell inhibition, since PD-L2-/PD-1 interaction skewed T cells toward T-helper cells type 2 (Th2) [61,110,111].”
BackgroundTIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
Sakuishi, K., Ngiow, S. F., Sullivan, J. M., Teng, M. W. L., Kuchroo, V. K., Smyth, M. J., & Anderson, A. C. (2013) · OncoImmunology · doi:10.4161/onci.23849 · Cited by 328 · cited 1×
“In particular, it has been documented that TIM-3+ Treg conferred stronger immunosuppressive capacities via increased IL-10 production and the inhibition of CTL as compared to their TIM-3−counterparts [186,187].”
BackgroundIDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Smith, C., Chang, M. Y., Parker, K. H., Beury, D. W., DuHadaway, J. B., Flick, H. E., Boulden, J., Sutanto-Ward, E., Soler, A. P., Laury-Kleintop, L. D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0014 · Cited by 322
Elkabets, M., Ribeiro, V. S. G., Dinarello, C. A., Ostrand‐Rosenberg, S., Di Santo, J. P., Apte, R. N., & Vosshenrich, C. A. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041037 · Cited by 319
Brandau, S., Trellakis, S., Bruderek, K., Schmaltz, D., Steller, G., Elian, M., Suttmann, H., Schenck, M., Welling, J., Zabel, P., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310162 · Cited by 315 · cited 2×
“Moreover, G-MDSC have shown a higher immunosuppressive activity, expressed higher levels of CD115 and CD244, and lower levels of CXCR1 than PMN [61,73].”
BackgroundFridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031524 · Cited by 311 · cited 2×
“revealed cell-specific transcriptome signatures of PMN, G-MDSC, and TAN, confirming the existence of three distinct phenotypes [62].”
BackgroundTim-3: An Emerging Target in the Cancer Immunotherapy Landscape
Anderson, A. C. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0039 · Cited by 305 · cited 1×
“In particular, it has been documented that TIM-3+ Treg conferred stronger immunosuppressive capacities via increased IL-10 production and the inhibition of CTL as compared to their TIM-3−counterparts [186,187].”
BackgroundIL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Zanon, A., Rossi, C. R., Nitti, D., Bronte, V., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803831 · Cited by 304
Moutsopoulos, N. M., Konkel, J., Sarmadi, M., Eskan, M. A., Wild, T., Dutzan, N., Abusleme, L., Zenobia, C., Hosur, K. B., Abe, T., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007696 · Cited by 303
Integrin CD11b activation drives anti-tumor innate immunity
Schmid, M. C., Khan, S. Q., Kaneda, M. M., Pathria, P., Shepard, R., Louis, T. L., Anand, S., Woo, G., Leem, C., Faridi, M. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07387-4 · Cited by 300 · cited 2×
“demonstrated that a pharmacological activation of CD11b promoted the pro-inflammatory macrophage polarization, which in turn impaired tumor growth in murine and human cancer models [241].”
BackgroundMitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.008 · Cited by 283
CD40 stimulation obviates innate sensors and drives T cell immunity in cancer
Byrne, K. T., & Vonderheide, R. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.058 · Cited by 282 · cited 1×
“Although the results may be contradictory at first glance, because CD40 is commonly known to induce adaptive immunity [191], the observations could reveal a crucial mechanism mediating MDSC immunosuppression.”
ResultTim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
Dardalhon, V., Anderson, A. C., Karman, J., Apetoh, L., Chandwaskar, R., Lee, D. H., Cornejo, M., Nishi, N., Yamauchi, A., Quintana, F. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903275 · Cited by 278 · cited 2×
“, the interaction of TIM-3+, IFN-γ-secreting T cells with Gal-9+ MDSC might add up to both MDSC expansion and immunosuppressive functions [120].”
BackgroundHe, Y., Yu, H., Rozeboom, L., Rivard, C. J., Ellison, K., Dziadziuszko, R., Suda, K., Ren, S., Wu, C., Hou, L., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.01.019 · Cited by 268 · cited 1×
“Notably, a strong cooperative effect between LAG-3, PD-1, and CTLA-4 has been elucidated in recent reports, highlighting the relevance of the interplay between these checkpoint molecules in the regulation of tumor immunity [184,185].”
BackgroundLi, L., Wang, L., Li, J., Fan, Z., Yang, L., Zhang, Z., Zhang, C., Yue, D., Qin, G., Zhang, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2460 · Cited by 266 · cited 1×
“Additionally, it was shown that the ADO-generating ectoenzymes CD39 and CD73 are upregulated by MDSC upon HIF-1α induction [94].”
BackgroundAdenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261 · cited 18×
“ADO serves as a potent immunosuppressive molecule, inhibiting effector immune cell populations via different adenosine receptors (A1, A2A, A2B, and A3).”
BackgroundInfluentialLFA-1 in T Cell Migration and Differentiation
Walling, B. L., & Kim, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00952 · Cited by 261 · cited 1×
“Moreover, β2 integrins are critically involved in the differentiation of immune cells [196], the migration into inflammatory tissues [197], as well as the extent and character of immune responses.”
BackgroundEmerging Tim-3 functions in antimicrobial and tumor immunity
Sakuishi, K., Jayaraman, P., Behar, S. M., Anderson, A. C., & Kuchroo, V. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.003 · Cited by 258 · cited 1×
“Next, it has been documented that Gal-9expression on MDSC induced T cell apoptosis via ligation to the checkpoint protein T cell immunoglobulin and mucin domain-containing protein (TIM)-3 [118].”
BackgroundJitschin, R., Braun, M., Büttner, M., Dettmer-Wilde, K., Bricks, J., Berger, J., Eckart, M. J., Krause, S. W., Oefner, P. J., Le Blanc, K., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546416 · Cited by 251 · cited 1×
“Both the depletion of L-tryptophan and the accumulation of kynurenines suppressed T cell activation and induced Treg in vitro [93,172].”
BackgroundBasis of CTLA-4 function in regulatory and conventional CD4+ T cells
Tai, X., Van Laethem, F., Pobezinsky, L., Guinter, T., Sharrow, S. O., Adams, A., Granger, L., Kruhlak, M., Lindsten, T., Thompson, C. B., et al. (2012) · Blood · doi:10.1182/blood-2011-11-388918 · Cited by 251 · cited 1×
“This interaction causes an impairment of APC-dependent T cell activation [108], enhances the immunosuppressive properties of Treg, and augments peripheral tolerance [109].”
BackgroundAntimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Mittal, D., Young, A., Stannard, K., Yong, M., Teng, M. W. L., Allard, B., Stagg, J., & Smyth, M. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0957 · Cited by 245
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function
Kurniawan, H., Franchina, D. G., Guerra, L., Bonetti, L., - Baguet, L. S., Grusdat, M., Schlicker, L., Hunewald, O., Dostert, C., Merz, M. P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.004 · Cited by 243
The kindlin family: functions, signaling properties and implications for human disease
Rognoni, E., Ruppert, R., & Fässler, R. (2016) · Journal of Cell Science · doi:10.1242/jcs.161190 · Cited by 240 · cited 8×
“Moreover, β2 integrins are critically involved in the differentiation of immune cells [196], the migration into inflammatory tissues [197], as well as the extent and character of immune responses. β2 integrins interact with various surface receptors, e.g., intercellular adhesion molecules (ICAM15), vascular cell adhes…”
BackgroundInfluentialResistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
Zhu, J., Powis de Tenbossche, C. G., Cané, S., Colau, D., van Baren, N., Lurquin, C., Schmitt-Verhulst, A.-M., Liljeström, P., Uyttenhove, C., & Van den Eynde, B. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00784-1 · Cited by 230 · cited 3×
“Despite conflicting reports about the role of Fas-(L)igand-Fas signaling for MDSC homeostasis and function [90,123], it is well documented that MDSC are able to induce T cell apoptosis via FasL [124].”
BackgroundDeng, J., Li, J., Sarde, A., Lines, J. L., Lee, Y.-C., Qian, D. C., Pechenick, D. A., Manivanh, R., Le Mercier, I., Lowrey, C. H., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0507 · Cited by 224 · cited 2×
“In particular, VISTA has been reported to enhance the inhibition of T cell [113,114] and B cell responses [115] by MDSC, whereas a blockade of VISTA allowed for the restoration of a protective anti-tumor response [116,117].”
BackgroundWu, L., Mao, L., Liu, J.-F., Chen, L., Yu, G.-T., Yang, L.-L., Wu, H., Bu, L.-L., Kulkarni, A. B., Zhang, W.-F., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0725 · Cited by 222 · cited 1×
“More recently, Wu and coworkers reported that the interaction of TIGIT and CD155 on MDSC might equally be involved in Treg–MDSC crosstalk [121,189], as it added up to the immunoregulatory functions of Treg [190] and MDSC [122].”
BackgroundChristmas, B. J., Rafie, C. I., Hopkins, A. C., Scott, B. A., Ma, H. S., Cruz, K. A., Woolman, S., Armstrong, T. D., Connolly, R. M., Azad, N. A., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0070 · Cited by 219
Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells
Liu, Y., Xiang, X., Zhuang, X., Zhang, S., Liu, C., Cheng, Z., Michalek, S., Grizzle, W., & Zhang, H.-G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090777 · Cited by 218 · cited 1×
“Here, the Toll-like receptor (TLR) family, namely TLR-4, which is triggered by S100A8 and S100A9 proteins, contributes to myeloid cell development via the downstream induction of nuclear factor-kB (NFκB), thus supporting the mobilization of myeloid cells to sites of inflammation and their inflammation-driven suppressi…”
BackgroundMemory of Inflammation in Regulatory T Cells
van der Veeken, J., Gonzalez, A. J., Cho, H., Arvey, A., Hemmers, S., Leslie, C. S., & Rudensky, A. Y. (2016) · Cell · doi:10.1016/j.cell.2016.07.006 · Cited by 201 · cited 1×
“Treg are defined as a T helper cell subpopulation characterized by the co-expression of CD4, CD25, and in large parts of FoxP3, which inhibit the activation and differentiation of CD4+ and CD8+ T cells, subsequently impairing reactivity against autologous and tumor-expressed antigens [130,133,134].”
BackgroundAhmadzadeh, M., Pasetto, A., Jia, L., Deniger, D. C., Stevanović, S., Robbins, P. F., & Rosenberg, S. A. (2019) · Science Immunology · doi:10.1126/sciimmunol.aao4310 · Cited by 201 · cited 6×
“The cooperative activities of Nox-2, Arginase (Arg)-1, and inducible nitric oxide synthase (iNOS) generate peroxynitrite, which drives protein nitration resulting in desensitization of the TCR and the interference with IL-2 receptor signaling.”
BackgroundInfluentialKochetkova, I., Golden, S., Holderness, K., Callis, G., & Pascual, D. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902739 · Cited by 200 · cited 2×
“Thus, it was suggested that IL-35 generation might establish another positive feedback loop between MDSC and Treg, contributing to the suppressive capacities of Treg [160].”
BackgroundSarhan, D., Cichocki, F., Zhang, B., Yingst, A., Spellman, S. R., Cooley, S., Verneris, M. R., Blazar, B. R., & Miller, J. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0839 · Cited by 200 · cited 2×
“More recently, Wu and coworkers reported that the interaction of TIGIT and CD155 on MDSC might equally be involved in Treg–MDSC crosstalk [121,189], as it added up to the immunoregulatory functions of Treg [190] and MDSC [122].”
BackgroundMyeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples
Kotsakis, A., Harasymczuk, M., Schilling, B., Georgoulias, V., Argiris, A., & Whiteside, T. L. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.04.004 · Cited by 199 · cited 1×
“Therefore, in vivo strategies and multi-omics approaches are vital to elucidate (combinations of) TME-derived factors that may induce the differentiation, expansion, activation, and interconversion of MDSC populations [24,76].”
BackgroundImmunoregulatory functions of VISTA
Nowak, E. C., Lines, J. L., Varn, F. S., Deng, J., Sarde, A., Mabaera, R., Kuta, A., Le Mercier, I., Cheng, C., & Noelle, R. J. (2017) · Immunological Reviews · doi:10.1111/imr.12525 · Cited by 197 · cited 10×
“Checkpoint molecules contribute t the crosstalk b tween MDSC nd Treg via PD-L1/PD-1, CD80/CTLA-4, MHC-II/LAG-3 V domain-containi g immu oglobulin sup ess r of T-c ll activation (VISTA)-Ligand/VISTA, Gal-9/TIM-3 (not shown), or CD155/TIGIT (not shown) interaction, promoting the suppressive activities of MDSC and Treg.”
BackgroundInfluentialContribution of regulatory T cells to cancer: A review
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27553 · Cited by 195 · cited 1×
“CD4+CD25hi Forkhead-Box-Protein P3 (FoxP3)+ Treg cells are frequently found in the course of tumor progression and counteract APC activity, T cell activation, and anti-tumor functions of effector T cells (Teff) [24,52].”
BackgroundMaçon‐Lemaître, L., & Triebel, F. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02145.x · Cited by 192 · cited 1×
“In this regard, Pinton and coworkers found that MDSC confer immunosuppression upon MHCII/LAG-3 interaction [178], whereas the blockade of LAG-3 increased the number of Teff [179].”
BackgroundZhou, M., Todd, R. F., van de Winkel, J. G., & Petty, H. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.7.3030 · Cited by 189 · cited 1×
“In particular, β2 integrins are considered critical components for the formation of the immunological synapse between APC and T cells and the intercellular communication of immune cells in general [193,200].”
BackgroundMetabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Guerra, L., Bonetti, L., & Brenner, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107848 · Cited by 189 · cited 4×
“On the one hand, autocrine PGE2 secretion by MDSC resulted in an enhanced IL-10 secretion and IDO expression in MDSC [98].”
BackgroundInfluentialTumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803926 · Cited by 186
Beury, D. W., Parker, K. H., Nyandjo, M., Sinha, P., Carter, K. A., & Ostrand-Rosenberg, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-210r · Cited by 183 · cited 1×
“The TME is a complex milieu being composed of a heterogeneous assemblage of distinct tumor—and host cell types such as cancer-associated fibroblasts (CAF), endothelial cells, pericytes, and immune cells that constitute the tumor parenchyma and tumor stroma [14,27].”
BackgroundWang, L., Jia, B., Claxton, D. F., Ehmann, W. C., Rybka, W. B., Mineishi, S., Naik, S., Khawaja, M. R., Sivik, J., Han, J., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1469594 · Cited by 180 · cited 1×
“In particular, VISTA has been reported to enhance the inhibition of T cell [113,114] and B cell responses [115] by MDSC, whereas a blockade of VISTA allowed for the restoration of a protective anti-tumor response [116,117].”
BackgroundLymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo
Durham, N. M., Nirschl, C. J., Jackson, C. M., Elias, J., Kochel, C. M., Anders, R. A., & Drake, C. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109080 · Cited by 178 · cited 1×
“As LAG-3 is essential for maximal Treg suppressive function, including the secretion of the immunosuppressive cytokines IL-10 and TGF-ß [181], the induction of Treg [182], and their differentiation toward a regulatory phenotype [183], it is conceivable that LAG-3/MHCII interaction between Treg and MDSC could mutually…”
BackgroundKim, J. Y., Kronbichler, A., Eisenhut, M., Hong, S. H., van der Vliet, H. J., Kang, J., Shin, J. I., & Gamerith, G. (2019) · Cancers · doi:10.3390/cancers11111798 · Cited by 165 · cited 1×
“, a high mutational load of the tumor cells [3,4], the presence of neoantigens [5,6], microsatellite instability [7,8], and host factors, i.”
BackgroundGranulocytes: New Members of the Antigen-Presenting Cell Family
Lin, A., & Loré, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01781 · Cited by 161 · cited 1×
“Accordingly, β2 integrins may constitute potential mediators of the crosstalk between MDSC and Treg [26].”
BackgroundTreg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance
Sullivan, J. A., Tomita, Y., Jankowska-Gan, E., Lema, D. A., Arvedson, M. P., Nair, A., Bracamonte-Baran, W., Zhou, Y., Meyer, K. K., Zhong, W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.081 · Cited by 161 · cited 1×
“First, it has been shown that Treg-derived soluble mediators, such as IL-10, TGF-β, and IL-35, suppress antigen presentation by DC, promote T cell exhaustion and CTL dysfunction [139,140].”
BackgroundHu, C.-E., Gan, J., Zhang, R.-D., Cheng, Y.-R., & Huang, G.-J. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.516450 · Cited by 161 · cited 1×
“Next to the interaction between MDSC and macrophages, MDSC impair DC function via the production of IL-10, which inhibits IL-12 production in DC and the subsequent DC-mediated activation of T cells [49,129].”
BackgroundSiret, C., Collignon, A., Silvy, F., Robert, S., Cheyrol, T., André, P., Rigot, V., Iovanna, J., van de Pavert, S., Lombardo, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03070 · Cited by 156 · cited 7×
“Here, the depletion of MDSC led to a significant reduction of intratumoral Treg, thus confirming, that MDSC have the ability to promote the de novo generation and recruitment of Treg [21,152].”
BackgroundMethodInfluentialFagerholm, S. C., Guenther, C., Llort Asens, M., Savinko, T., & Uotila, L. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00254 · Cited by 156 · cited 1×
“, MDSC, TAM, and PMN) within the TME [247], which induce tolerance and thus support tumor growth and progression.”
BackgroundThe diversity of circulating neutrophils in cancer
Mishalian, I., Granot, Z., & Fridlender, Z. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.02.001 · Cited by 155
Sinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A., & Ostrand-Rosenberg, S. (2011) · Blood · doi:10.1182/blood-2010-11-321752 · Cited by 154 · cited 2×
“Despite conflicting reports about the role of Fas-(L)igand-Fas signaling for MDSC homeostasis and function [90,123], it is well documented that MDSC are able to induce T cell apoptosis via FasL [124].”
BackgroundIannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2013) · Neoplasia · doi:10.1593/neo.131748 · Cited by 152 · cited 3×
“In agreement, the blockade of A2B receptor with a selective antagonist reduced the number of tumor-infiltrating MDSC and improved T cell-mediated immune surveillance in a melanoma model [95].”
BackgroundRegulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
Fujimura, T., Ring, S., Umansky, V., Mahnke, K., & Enk, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.416 · Cited by 148 · cited 2×
“PD-1/ PD-L1, IL-10 Treg, MDSC and CD4+ T cells mouse Ret-melanoma Depletion of Treg downregulated PD-L1 expression on MDSC and inhibited IL-10 production Diminished PD-L1 expression on MDSC led to a reduced inhibition of CD4+ T cells iNOS expression was not affected by Treg depletion [154]”
BackgroundKondo, Y., Ohno, T., Nishii, N., Harada, K., Yagita∥, H., & Azuma, M. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.04.005 · Cited by 147 · cited 1×
“In particular, VISTA has been reported to enhance the inhibition of T cell [113,114] and B cell responses [115] by MDSC, whereas a blockade of VISTA allowed for the restoration of a protective anti-tumor response [116,117].”
BackgroundXu, W., Hiếu, T., Malarkannan, S., & Wang, L. L. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.148 · Cited by 145 · cited 1×
“MDSC [114], might mediate the crosstalk between MDSC and Treg, thus enhancing their immunosuppressive capacity [174].”
BackgroundLee, C.-R., Kwak, Y., Yang, T., Han, J. H., Park, S.-H., Ye, M. B., Lee, W., Sim, K.-Y., Kang, J.-A., Kim, Y.-C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.062 · Cited by 141 · cited 3×
“TGF-β Treg and MDSC mouse Murine colitis Treg-derived TGF-β enhanced Arg-1, PD-L1, and iNOS expression on MDSC, thus promoting their immunosuppressive properties MDSC themselves showed a stronger induction of Treg after TGF-β stimulation [153]”
BackgroundInfluentialWang, L., Gordon, R. A., Huynh, L., Su, X., Min, K.-H. P., Han, J., Arthur, J. S., Kalliolias, G. D., & Ivashkiv, L. B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.014 · Cited by 140 · cited 1×
“First, it has been shown that the ligation of β2 integrins in macrophages might impair type I interferon receptor activation, TLR signaling, and induced IL-10 expression, thus enhancing their immunosuppressive capacities [242].”
BackgroundImbert, C., Montfort, A., Fraisse, M., Marcheteau, E., Gilhodes, J., Martin, E., Bertrand, F. A., Marcellin, M., Burlet‐Schiltz, O., de Peredo, A. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14218-7 · Cited by 140 · cited 1×
“More interestingly, the extent of Treg infiltration into human tumors has been proposed to show an inverse correlation with the response to ICI therapy [131,132].”
BackgroundWu, Y., Xu, J., Du, C., Wu, Y., Xia, D., Lv, W., & Hu, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01161 · Cited by 139 · cited 1×
“, a high mutational load of the tumor cells [3,4], the presence of neoantigens [5,6], microsatellite instability [7,8], and host factors, i.”
BackgroundRole of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Li, Q., Pan, P.-Y., Gu, P., Xu, D., & Chen, S.-H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1715 · Cited by 135
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
Pinton, L., Solito, S., Damuzzo, V., Francescato, S., Pozzuoli, A., Berizzi, A., Mocellin, S., Rossi, C. R., Bronte, V., & Mandruzzato, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6662 · Cited by 133 · cited 1×
“In this regard, Pinton and coworkers found that MDSC confer immunosuppression upon MHCII/LAG-3 interaction [178], whereas the blockade of LAG-3 increased the number of Teff [179].”
BackgroundKim, K.-J., Lee, K. S., Cho, H. J., Kim, Y. H., Yang, H. K., Kim, W. H., & Kang, G. H. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.09.004 · Cited by 132 · cited 3×
“Similar to TAM and MDSC, Treg contribute to Arg-1 mediated arginine depletion within the TME [142].”
BackgroundActivated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair
Aarts, C. E. M., Hiemstra, I. H., Béguin, E. P., Hoogendijk, A. J., Bouchmal, S., van Houdt, M., Tool, A. T. J., Mul, E. P. J., Jansen, M. H., Janssen, H., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019031609 · Cited by 132 · cited 3×
“Accordingly, the blockade of ICAM-1 reduced T cell suppression by approximately 50%, suggesting that additional molecules might be involved in Mac-1/ICAM interaction [227].”
BackgroundResultInfluentialTumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L.-X., Cohen, P. A., & Shu, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3291 · Cited by 131 · cited 1×
“G-MDSC and M-MDSC apply antigen-specific and antigen-non-specific mechanisms to regulate immune responses and thus inhibit Teff via a plethora of mechanisms [24]: In peripheral lymphoid organs, the MDSC-mediated suppression of CTL usually requires antigen presentation by MDSC and direct MDSC/T cell contact [87,88].”
BackgroundTumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
Fujimura, T., Kambayashi, Y., Fujisawa, Y., Hidaka, T., & Aiba, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00003 · Cited by 129 · cited 20×
“Moreover, β2 integrins play a pivotal role in the communication of tumor cells and myeloid cells (e.g., MDSC, TAM, and PMN) within the TME [247], which induce tolerance and thus support tumor growth and progression.”
BackgroundInfluentialIntegrin α4β1 Promotes Monocyte Trafficking and Angiogenesis in Tumors
Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., & Varner, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2704 · Cited by 127
Kalia, V., Penny, L. A., Yuzefpolskiy, Y., Baumann, F. M., & Sarkar, S. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.023 · Cited by 126 · cited 16×
“Furthermore, Treg hamper anti-tumor immunity via the interaction of CTLA-4 with the co-stimulatory receptors CD80 and CD86, which are expressed by APC-like DC, resulting in the inhibition Cancers 2021, 13, 210 12 of 34 of their T cell stimulatory capacity [130,147].”
BackgroundInfluentialMapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
Vanderstraeten, A., Luyten, C., Verbist, G., Tuyaerts, S., & Amant, F. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1537-8 · Cited by 126 · cited 1×
“Youn and coworkers additionally suggested that PD-L2 might add up to MDSCinduced T cell inhibition, since PD-L2-/PD-1 interaction skewed T cells toward T-helper cells type 2 (Th2) [61,110,111].”
BackgroundTargeting myeloid cells in the tumor sustaining microenvironment
Schupp, J., Krebs, F. K., Zimmer, N., Trzeciak, E., Schuppan, D., & Tuettenberg, A. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.013 · Cited by 126 · cited 3×
“These factors prevent APC maturation, impair Teff functions, and thus counteract the tumoricidal functions of activated immune effector cells [14,24,46,53].”
BackgroundLiu, J.-F., Wu, L., Yang, L.-L., Deng, W.-W., Mao, L., Wu, H., Zhang, W.-F., & Sun, Z.-J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0713-7 · Cited by 125 · cited 1×
“suggested that the interaction of MDSC-expressed Gal-9 and TIM-3 on Treg might drive MDSC expansion and suppressive activity [120], whereas a blockade of TIM-3 restored anti-tumor immunity by decreasing Treg numbers, their inhibitory capacity, and MDSC-mediated T cell inhibition [188].”
BackgroundFujimura, T., Kambayashi, Y., & Aiba, S. (2012) · OncoImmunology · doi:10.4161/onci.21176 · Cited by 122 · cited 1×
“By contrast, Fujimura and coworkers observed an upregulation of PD-L1 on tumorinfiltrating MDSC in a ret-melanoma model and thus proposed that PD-L1/PD-1 interaction might contribute to the immunosuppressive activities of Treg and the inhibition of T cell proliferation [22].”
ResultAdaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Sarhan, D., Hippen, K. L., Lemire, A., Hying, S., Luo, X., Lenvik, T., Curtsinger, J., Davis, Z., Zhang, B., Cooley, S., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0498 · Cited by 121 · cited 1×
“Lastly, Treg hampered Teff and NK cell function and activity via immunosuppressive receptor interactions and the application of cytotoxic enzymes [145].”
Backgroundβ2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
Bednarczyk, M., Stege, H. M., Grabbe, S., & Bros, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041402 · Cited by 121
Self-citationRole of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Ryzhov, S. V., Pickup, M. W., Chytil, A., Gorska, A. E., Zhang, Q., Owens, P., Feoktistov, I., Moses, H. L., & Novitskiy, S. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400578 · Cited by 118 · cited 1×
“In accordance with these observations, ADO production serves as an additional mechanism promoting MDSC-mediated immunosuppression, since ADO augmented the accumulation of MDSC within tumor lesions and their immunosuppressive activity [165,166].”
BackgroundGalectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
Zhang, C.-X., Huang, D.-J., Baloche, V. M. D., Zhang, L., Xu, J.-X., Li, B., Zhao, X., He, J., Mai, H., Chen, Q., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00248-0 · Cited by 117 · cited 2×
“Abbreviations A2AR Adenosine A2 Receptor ADAM17 ADAM Metallopeptidase Domain 17 ADO Extracellular adenosine AMP Adenosine monophosphate APC Antigen-presenting cells Arg-1 Arginase-1 ATP Adenosine triphosphate ATRA All-trans retinoic acid BM Bone marrow CAF Cancer-associated fibroblasts cAMP Cyclical adenosine monophos…”
BackgroundCD103 is a hallmark of tumor‐infiltrating regulatory T cells
Anz, D., Mueller, W., Golic, M., Kunz, W. G., Rapp, M., Koelzer, V. H., Ellermeier, J., Ellwart, J. W., Schnurr, M., Bourquin, C., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25902 · Cited by 116 · cited 1×
“Indeed, in the context of tumor immunity, it has been shown that tumor-infiltrating Treg expressed significantly higher levels of Integrin αE (CD103) than peripheral Tregs and that CD103+ Treg displayed a more suppressive phenotype [221].”
BackgroundAi, L., Mu, S., Wang, Y., Wang, H., Cai, L., Li, W., & Hu, Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-5086-y · Cited by 116 · cited 1×
“Next to the immunosuppressive effects conferred by soluble mediators and leukocyte receptor interactions, the extensive infiltration of the tumor by immunosuppressive cell populations, such as tumor-associated macrophages (TAM) [16,17], myeloid-derived suppressor cells (MDSC) [18], and regulatory T cells (Treg) [19,20…”
BackgroundFaridi, M. H., Khan, S. Q., Zhao, W., Lee, H. W., Altintas, M. M., Zhang, K., Kumar, V., Armstrong, A. R., Carmona-Rivera, C., Dorschner, J. M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88442 · Cited by 111 · cited 2×
“In accordance with these findings, the importance of LFA-1, expressed on T cells, for the induction of tolerance and the suppression of inflammation has been documented in various autoimmune diseases, such as experimental autoimmune encephalitis (EAE) [208,209], systemic sclerosis [210,211], rheumatoid arthritis, psor…”
BackgroundResultYang, M., Ma, C., Liu, S., Shao, Q., Gao, W., Song, B., Sun, J., Xie, Q., Zhang, Y., Feng, A., et al. (2010) · Immunology & Cell Biology · doi:10.1038/icb.2009.77 · Cited by 110 · cited 1×
“Moreover, the upregulation of HIF-1α by myeloid cells within the TME has been shown to induce the expression of the A2B receptor, causing a differentiation arrest of myeloid cells, subsequently promoting the accumulation of MDSC [167].”
Background
Cited by
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
“In addition, Treg cells in the TME convert ATP into adenosine, inhibiting the activity of immune cells in tumors (Lindau et al., 2013; Peixoto et al., 2019; Haist et al., 2021).”
BackgroundAdvances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270
He, S., Zheng, L., & Qi, C. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02208-3 · Cited by 227
Exploiting innate immunity for cancer immunotherapy
Yi, M., Li, T., Niu, M., Mei, Q., Zhao, B., Chu, Q., Dai, Z., & Wu, K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01885-w · Cited by 225
Metadata
- Authors
- Haist, M., Stege, H., Grabbe, S., & Bros, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Haist, Maximilian
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-01-08
- Volume
- 13
- Issue
- 2
- Pages
- 210
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC7827203
- OpenAlex
- W3119068311
- Cited by
- 295
- References
- 267
- Citations by year
- 2026: 100 · 2025: 69 · 2024: 42 · 2023: 35 · 2022: 32 · 2021: 17
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Else Kröner Fresenius Foundation (TransMed Jumpstart Program: 2019_A72)
- Deutsche Forschungsgemeinschaft (SFB_1066 (B4,B5), TR156 (B11))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- myeloid-derived suppressor cells, regulatory T cells, tumor microenvironment, immunosuppression, immune checkpoint inhibitors, immune resistance, cell-cell crosstalk, adhesion molecules, beta2 integrins, tumor-associated macrophages, immunotherapy targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.